INFOGRAPHIC: Catalina Reports Impact of ‘Tripledemic’ on Sales of OTC Remedies for Flu & RSV
The U.S. 'tripledemic' is in full swing causing unit sales of over the counter (OTC) treatment categories to rise by as much as 70%. New COVID variants, an early and more serious flu season, plus a sharp uptick of respiratory virus infections (RSV) contributed to OTC cough, cold, RSV, and flu symptom-related products climbing an average of 19% for October-November 2022 compared to the same period a year ago.
